Revenio Group Oyj — Director's Dealing 2022

May 20, 2022

Revenio Group Corporation: Managers' Transactions – Heli Huopaniemi

Revenio Group Corporation, Managers' transactions, May 20, 2022 at 4.00 p.m. (EEST)

Revenio Group Oyj: Managers' Transactions – Heli Huopaniemi

____________________________________________ Person subject to the notification requirement Name: Heli Huopaniemi Position: Other senior manager Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 15340/6/6

____________________________________________

Transaction date: 2022-05-19 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009010912 Nature of the transaction: DISPOSAL

Transaction details (1): Volume: 800 Unit price: 45.4 EUR Aggregated transactions (1): Volume: 800 Volume weighted average price: 45.4 EUR

For further information, please contact:

CFO Robin Pulkkinen, tel. +358 50 505 9932 robin.pulkkinen@revenio.fi www.revenio.fi

DISTRIBUTION: Nasdaq Helsinki Ltd Main media www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical

software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare software solutions provide eye care professionals with new innovative digital clinical tools that drive greater efficiency and enhance the quality of care.

In 2021, the Group's net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Heli Huopaniemi